Dr Matthias Degroote is currently investigating the application of quantum computers in drug design at Boehringer Ingelheim. His expertise spans both classical and quantum computing approaches to the quantum many-body problem. Matthias earned his PhD in physics from Ghent University, where his research focused on Green’s functions. His academic journey continued with postdoctoral research in method development at Ghent University and Rice University. Since 2018, his research has concentrated on the field of quantum computing. He has held prestigious postdoctoral positions at both Harvard University and the University of Toronto. Dr Degroote’s work at the intersection of quantum computing and drug design is pioneering. By leveraging quantum computers, he aims to revolutionize the drug design process, making it more efficient and effective. His unique approach and innovative research are expected to bring fresh perspectives to Digital Discovery, enhancing the quality and scope of our publications.
期刊介绍
rsc.li/digitaldiscovery
Digital Discovery
2-年影响因子*
6.2分
5-年影响因子*
6.2分
JCR 分区*
Q1 计算机科学 - 跨学科应用 Q1化学-跨学科
CiteScore 分†
2.8分(
中位一审周期‡
55天
Digital Discovery 以数字化技术和自动化工具与基础科学的相互结合为重点，将囊括人工智能、实验自动化、机器人技术、数据库和先进 数据分析等领域的创新成果。本刊发表的研究工作范围广阔，但需有坚实的化学基础，具体包括：
